APA (7th ed.) Citation

W, Z., S, D., H, F., N, Y., L, X., Z, L., . . . X, P. (2026). Oncolytic virus-delivered CEACAM6/CD3 BiTEs combine with PD-1 blockade to achieve synergistic anticancer efficacy. Pharmacological research, 232, 108392. https://doi.org/10.1016/j.phrs.2026.108392

Chicago Style (17th ed.) Citation

W, Zhang, et al. "Oncolytic Virus-delivered CEACAM6/CD3 BiTEs Combine with PD-1 Blockade to Achieve Synergistic Anticancer Efficacy." Pharmacological Research 232 (2026): 108392. https://doi.org/10.1016/j.phrs.2026.108392.

MLA (9th ed.) Citation

W, Zhang, et al. "Oncolytic Virus-delivered CEACAM6/CD3 BiTEs Combine with PD-1 Blockade to Achieve Synergistic Anticancer Efficacy." Pharmacological Research, vol. 232, 2026, p. 108392, https://doi.org/10.1016/j.phrs.2026.108392.